Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE GAMMA BUTYROLACTONE MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 GRADE LIFE LINE CURVE
2.7 MULTIVARIATE MODELING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END-USE COVERAGE GRID
2.11 DBMR MARKET CHALLENGE MATRIX
2.12 DBMR VENDOR SHARE ANALYSIS
2.13 IMPORT-EXPORT DATA
2.14 SECONDARY SOURCES
2.15 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.1.1 POLITICAL FACTORS
4.1.2 ECONOMIC FACTORS
4.1.3 SOCIAL FACTORS
4.1.4 TECHNOLOGICAL FACTORS
4.1.5 LEGAL FACTORS
4.1.6 ENVIRONMENTAL FACTORS
4.2 PORTER'S FIVE FORCES:
4.2.1 THREAT OF NEW ENTRANTS:
4.2.2 THREAT OF SUBSTITUTES:
4.2.3 CUSTOMER BARGAINING POWER:
4.2.4 SUPPLIER BARGAINING POWER:
4.2.5 INTERNAL COMPETITION (RIVALRY):
4.3 CLIMATE CHANGE SCENARIO
4.3.1 ENVIRONMENTAL CONCERNS
4.3.2 INDUSTRY RESPONSE
4.3.3 GOVERNMENT'S ROLE
4.3.4 ANALYST RECOMMENDATION
4.4 LIST OF KEY PATENTS LAUNCHED
4.5 SUPPLY CHAIN ANALYSIS
4.5.1 OVERVIEW
4.5.2 LOGISTIC COST SCENARIO
4.5.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
4.6 VENDOR SELECTION CRITERIA
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING APPLICATION OF DERIVED CHEMICAL PRODUCTS
5.1.2 APPLICATION IN A WIDE RANGE OF INDUSTRIES
5.1.3 INCREASED DEMAND FOR ELECTRONIC ITEMS
5.2 RESTRAINTS
5.2.1 SERIOUS HEALTH EFFECTS AND SAFETY CONCERNS
5.2.2 STRINGENT RULES AND REGULATIONS
5.3 OPPORTUNITIES
5.3.1 RISE IN DEMAND FOR ELECTRIC VEHICLES
5.3.2 INCREASE IN USAGE OF ORGANIC AGROCHEMICALS
5.4 CHALLENGES
5.4.1 GOVERNMENT RESTRICTIONS FOR ILLEGAL USAGE
6 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE
6.1 OVERVIEW
6.2 INDUSTRIAL CLASS (5 WT.%)
6.3 ELECTRIC CAPACITANCE CLASS (9 WT.%)
6.4 COMMON CLASS (8 WT.%)
7 EUROPE GAMMA BUTYROLACTONE MARKET, BY PURITY
7.1 OVERVIEW
7.2 MIN. 99.9%
7.3 MIN. 99.7%
8 EUROPE GAMMA BUTYROLACTONE MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 SOLVENT
8.3 CASTING BINDER
8.4 HERBICIDES AND INSECTICIDES
8.5 BATTERIES AND CAPACITORS
8.6 PAINT STRIPPERS
8.7 POLISH REMOVERS
8.8 ANESTHETIC
8.9 SEDATIVE
8.1 OTHERS
9 EUROPE GAMMA BUTYROLACTONE MARKET, BY END-USE
9.1 OVERVIEW
9.2 PHARMACEUTICAL INDUSTRY
9.3 ELECTRICAL INDUSTRY
9.4 AGROCHEMICAL INDUSTRY
9.5 PETROLEUM INDUSTRY
9.6 FOOD INDUSTRY
9.7 OTHERS
10 EUROPE GAMMA BUTYROLACTONE MARKET, BY REGION
10.1 EUROPE
10.1.1 FRANCE
10.1.2 GERMANY
10.1.3 U.K.
10.1.4 ITALY
10.1.5 TURKEY
10.1.6 BELGIUM
10.1.7 SPAIN
10.1.8 RUSSIA
10.1.9 SWITZERLAND
10.1.10 NETHERLANDS
10.1.11 REST OF EUROPE
11 EUROPE GAMMA BUTYROLACTONE MARKET: COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: EUROPE
11.2 RECOGNITION
11.3 AWARD
11.4 EVENT
11.5 EXPANSION
11.6 AGREEMENT
12 SWOT ANALYSIS
13 COMPANY PROFILES
13.1 MITSUBISHI CHEMICAL CORPORATION.
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.2 BASF SE
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENT
13.3 SIPCHEM COMPANY
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.4 BALAJI AMINES
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.5 ASHLAND
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENT
13.6 BIOSYNTH
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENT
13.7 BOAI NKY PHARMACEUTICALS LTD.
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENT
13.8 BYN CHEMICALS CO., LTD
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENT
13.9 DCC
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENT
13.1 ZHEJIANG REALSUN CHEMICAL CO.,LTD.
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.10.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
List of Table
TABLE 1 IMPORT DATA OF LACTONES; HS CODE – 293220 (USD THOUSAND)
TABLE 2 EXPORT DATA OF LACTONES; HS CODE – 293220 (USD THOUSAND)
TABLE 3 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 4 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 5 EUROPE INDUSTRIAL CLASS (5 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 6 EUROPE INDUSTRIAL CLASS (5 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS)
TABLE 7 EUROPE ELECTRIC CAPACITANCE CLASS (9 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 8 EUROPE ELECTRIC CAPACITANCE CLASS (9 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS)
TABLE 9 EUROPE COMMON CLASS (8 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 10 EUROPE COMMON CLASS (8 WT.%) IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (TONS)
TABLE 11 EUROPE GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 12 EUROPE MIN. 99.9% IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 13 EUROPE MIN. 99.7% IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 14 EUROPE GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 15 EUROPE SOLVENT IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 16 EUROPE CASTING BINDER IN EUROPE GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 17 EUROPE HERBICIDES AND INSECTICIDES IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 18 EUROPE BATTERIES AND CAPACITORS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 19 EUROPE PAINT STRIPPERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 20 EUROPE POLISH REMOVERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 21 EUROPE ANESTHETIC IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 22 EUROPE SEDATIVE IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 23 EUROPE OTHERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 24 EUROPE GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 25 EUROPE PHARMACEUTICAL INDUSTRY IN EUROPE GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 26 EUROPE ELECTRICAL INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 27 EUROPE AGROCHEMICAL INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 28 EUROPE PETROLEUM INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 29 EUROPE FOOD INDUSTRY IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 30 EUROPE OTHERS IN GAMMA BUTYROLACTONE MARKET, BY REGION, 2017-2030 (USD THOUSAND)
TABLE 31 EUROPE GAMMA BUTYROLACTONE MARKET, BY COUNTRY, 2017-2030 (USD THOUSAND)
TABLE 32 EUROPE GAMMA BUTYROLACTONE MARKET, BY COUNTRY, 2017-2030 (TONS)
TABLE 33 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 34 EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 35 EUROPE GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 36 EUROPE GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 37 EUROPE GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 38 FRANCE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 39 FRANCE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 40 FRANCE GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 41 FRANCE GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 42 FRANCE GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 43 GERMANY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 44 GERMANY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 45 GERMANY GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 46 GERMANY GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 47 GERMANY GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 48 U.K. GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 49 U.K. GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 50 U.K. GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 51 U.K. GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 52 U.K. GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 53 ITALY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 54 ITALY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 55 ITALY GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 56 ITALY GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 57 ITALY GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 58 TURKEY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 59 TURKEY GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 60 TURKEY GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 61 TURKEY GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 62 TURKEY GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 63 BELGIUM GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 64 BELGIUM GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 65 BELGIUM GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 66 BELGIUM GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 67 BELGIUM GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 68 SPAIN GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 69 SPAIN GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 70 SPAIN GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 71 SPAIN GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 72 SPAIN GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 73 RUSSIA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 74 RUSSIA GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 75 RUSSIA GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 76 RUSSIA GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 77 RUSSIA GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 78 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 79 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 80 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 81 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 82 SWITZERLAND GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 83 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 84 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
TABLE 85 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY PURITY, 2017-2030 (USD THOUSAND)
TABLE 86 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY APPLICATION, 2017-2030 (USD THOUSAND)
TABLE 87 NETHERLANDS GAMMA BUTYROLACTONE MARKET, BY END-USE, 2017-2030 (USD THOUSAND)
TABLE 88 REST OF EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (USD THOUSAND)
TABLE 89 REST OF EUROPE GAMMA BUTYROLACTONE MARKET, BY GRADE, 2017-2030 (TONS)
List of Figure
FIGURE 1 EUROPE GAMMA BUTYROLACTONE MARKET
FIGURE 2 EUROPE GAMMA BUTYROLACTONE MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE GAMMA BUTYROLACTONE MARKET: DROC ANALYSIS
FIGURE 4 EUROPE GAMMA BUTYROLACTONE MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE GAMMA BUTYROLACTONE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE GAMMA BUTYROLACTONE MARKET: THE GRADE LIFE LINE CURVE
FIGURE 7 EUROPE GAMMA BUTYROLACTONE MARKET: MULTIVARIATE MODELLING
FIGURE 8 EUROPE GAMMA BUTYROLACTONE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 EUROPE GAMMA BUTYROLACTONE MARKET: DBMR MARKET POSITION GRID
FIGURE 10 EUROPE GAMMA BUTYROLACTONE MARKET: MARKET END-USE COVERAGE GRID
FIGURE 11 EUROPE GAMMA BUTYROLACTONE MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 12 EUROPE GAMMA BUTYROLACTONE MARKET: VENDOR SHARE ANALYSIS
FIGURE 13 EUROPE GAMMA BUTYROLACTONE MARKET: SEGMENTATION
FIGURE 14 GROWING APPLICATION OF DERIVED CHEMICAL PRODUCTS IS EXPECTED TO DRIVE THE EUROPE GAMMA BUTYROLACTONE MARKET GROWTH IN THE FORECAST PERIOD
FIGURE 15 INDUSTRIAL CLASS (5 WT. %) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE GAMMA BUTYROLACTONE MARKET IN 2022 & 2029
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE OF THE EUROPE GAMMA BUTYROLACTONE MARKET
FIGURE 17 EUROPE GAMMA BUTYROLACTONE MARKET: BY GRADE, 2022
FIGURE 18 EUROPE GAMMA BUTYROLACTONE MARKET: BY PURITY, 2022
FIGURE 19 EUROPE GAMMA BUTYROLACTONE MARKET: BY APPLICATION, 2022
FIGURE 20 EUROPE GAMMA BUTYROLACTONE MARKET: BY END-USE, 2022
FIGURE 21 EUROPE GAMMA BUTYROLACTONE MARKET: SNAPSHOT (2022)
FIGURE 22 EUROPE GAMMA BUTYROLACTONE MARKET: BY COUNTRY (2022)
FIGURE 23 EUROPE GAMMA BUTYROLACTONE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 24 EUROPE GAMMA BUTYROLACTONE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 25 EUROPE GAMMA BUTYROLACTONE MARKET: BY GRADE (2023 - 2030)
FIGURE 26 EUROPE GAMMA BUTYROLACTONE MARKET: COMPANY SHARE 2022 (%)
